Akebia Therapeutics reported $23.02M in Cost of Sales for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Acadia Pharmaceuticals ACAD:US $ 2.95M 0.39M
Akebia Therapeutics AKBA:US $ 23.02M 19.35M
Alnylam Pharmaceuticals ALNY:US $ 35.63M 2.04M
Amgen AMGN:US $ 1561M 157M
Ardelyx ARDX:US $ 0.08M 0.08M
Astellas Pharma 4503:JP Y 58915M 10444M
AstraZeneca AZN:LN 2279M 790M
Bayer BAYN:GR € 5176M 1491M
Biomarin Pharmaceutical BMRN:US $ 116.96M 2.78M
Exelixis EXEL:US $ 13.2M 0.29M
Fresenius Medical Care FME:GR € 3290.27M 37.59M
GlaxoSmithKline GSK:LN 3645M 30M
Intercept Pharmaceuticals ICPT:US $ 0.76M 0.26M
IONIS PHARMACEUT IONS:US $ 4.17M 1.94M
Karyopharm Therapeutics KPTI:US $ 1.43M 684K
Moderna Inc MRNA:US 1.02B 65M
Nektar Therapeutics NKTR:US $ 6.16M 0.85M
Opko Health OPK:US $ 243.88M 48.95M
Ptc Therapeutics PTCT:US $ 10.14M 0.81M
Vanda Pharmaceuticals VNDA:US $ 5.66M 0.57M